The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis

Abstract Background Intracardiac leiomyomatosis (ICLM) is a rare life-threatening form of intravenous leiomyomatosis (IVLM). The incomplete resection and recurrence are associated with high morbidity and mortality. The objective of this study is to identify that whether estrogen deprivation therapie...

Full description

Bibliographic Details
Main Authors: Jinxiao Liang, Ruilin Lei, Mingwei Xie, Shaodan Lin, Jing Xu, Xiaoting Ling, Qingsheng Xie
Format: Article
Language:English
Published: BMC 2021-10-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-021-02087-7
_version_ 1819011162466942976
author Jinxiao Liang
Ruilin Lei
Mingwei Xie
Shaodan Lin
Jing Xu
Xiaoting Ling
Qingsheng Xie
author_facet Jinxiao Liang
Ruilin Lei
Mingwei Xie
Shaodan Lin
Jing Xu
Xiaoting Ling
Qingsheng Xie
author_sort Jinxiao Liang
collection DOAJ
description Abstract Background Intracardiac leiomyomatosis (ICLM) is a rare life-threatening form of intravenous leiomyomatosis (IVLM). The incomplete resection and recurrence are associated with high morbidity and mortality. The objective of this study is to identify that whether estrogen deprivation therapies, including bilateral salpingo-oophorectomy (BSO)-based surgery and gonadotrophin releasing hormone agonists (GnRHa) administration, could bring benefits to patients with primary unresectable ICLM. Methods PubMed/MEDLINE (Ovid) was searched (up to May 2021) for studies reporting individual patient data on demographics, clinicopathological features, treatment, and follow-up information. Exclusion criteria were patients who may have been included in two or more publications. This study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results A total of 114 patients from 70 papers were included. Several reports showed that the tumor in the right atrium and inferior vena cava shrank dramatically after BSO-based surgery, or GnRHa administrated preoperatively in premenopausal women. The rate of complete resection was 64.04% in patients with ICLM, which was 85.25% in no/slight adhesion and no pulmonary nodules group, while 22.22% in firm/extensive adhesion and/or pulmonary nodules group (p < 0.0001). Meanwhile, the recurrence rates in patients with complete resection and incomplete resection were 4.29% and 37.84% respectively (p < 0.0001). Furthermore, complete resection with BSO had the lowest recurrence rate of 3.13%, incomplete resection with BSO had a progression rate of 45.45%, while incomplete resection with ovarian preservation had the highest progression rate of 75.00%. Conclusions The recurrence rate of ICLM was closely related to firm/extensive adhesion in IVC or above, and/or pulmonary nodules. BSO-based surgery might reduce the recurrence rate no matter ICLM could be completely resected or not. In addition, estrogen deprivation therapies could decrease tumor burden as a primary treatment, and further make a secondary complete resection feasible in premenopausal women with initially unresectable ICLM.
first_indexed 2024-12-21T01:23:46Z
format Article
id doaj.art-2131daa6b80740fea27be50244e79f53
institution Directory Open Access Journal
issn 1750-1172
language English
last_indexed 2024-12-21T01:23:46Z
publishDate 2021-10-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj.art-2131daa6b80740fea27be50244e79f532022-12-21T19:20:34ZengBMCOrphanet Journal of Rare Diseases1750-11722021-10-011611710.1186/s13023-021-02087-7The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysisJinxiao Liang0Ruilin Lei1Mingwei Xie2Shaodan Lin3Jing Xu4Xiaoting Ling5Qingsheng Xie6Department of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityDepartment of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityDepartment of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityDepartment of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityDepartment of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityDepartment of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityDepartment of Gynecological Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen UniversityAbstract Background Intracardiac leiomyomatosis (ICLM) is a rare life-threatening form of intravenous leiomyomatosis (IVLM). The incomplete resection and recurrence are associated with high morbidity and mortality. The objective of this study is to identify that whether estrogen deprivation therapies, including bilateral salpingo-oophorectomy (BSO)-based surgery and gonadotrophin releasing hormone agonists (GnRHa) administration, could bring benefits to patients with primary unresectable ICLM. Methods PubMed/MEDLINE (Ovid) was searched (up to May 2021) for studies reporting individual patient data on demographics, clinicopathological features, treatment, and follow-up information. Exclusion criteria were patients who may have been included in two or more publications. This study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results A total of 114 patients from 70 papers were included. Several reports showed that the tumor in the right atrium and inferior vena cava shrank dramatically after BSO-based surgery, or GnRHa administrated preoperatively in premenopausal women. The rate of complete resection was 64.04% in patients with ICLM, which was 85.25% in no/slight adhesion and no pulmonary nodules group, while 22.22% in firm/extensive adhesion and/or pulmonary nodules group (p < 0.0001). Meanwhile, the recurrence rates in patients with complete resection and incomplete resection were 4.29% and 37.84% respectively (p < 0.0001). Furthermore, complete resection with BSO had the lowest recurrence rate of 3.13%, incomplete resection with BSO had a progression rate of 45.45%, while incomplete resection with ovarian preservation had the highest progression rate of 75.00%. Conclusions The recurrence rate of ICLM was closely related to firm/extensive adhesion in IVC or above, and/or pulmonary nodules. BSO-based surgery might reduce the recurrence rate no matter ICLM could be completely resected or not. In addition, estrogen deprivation therapies could decrease tumor burden as a primary treatment, and further make a secondary complete resection feasible in premenopausal women with initially unresectable ICLM.https://doi.org/10.1186/s13023-021-02087-7Intracardiac leiomyomatosisEstrogen deprivation therapyPrimary treatmentBilateral salpingo-oophorectomyGonadotrophin releasing hormone agonists
spellingShingle Jinxiao Liang
Ruilin Lei
Mingwei Xie
Shaodan Lin
Jing Xu
Xiaoting Ling
Qingsheng Xie
The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis
Orphanet Journal of Rare Diseases
Intracardiac leiomyomatosis
Estrogen deprivation therapy
Primary treatment
Bilateral salpingo-oophorectomy
Gonadotrophin releasing hormone agonists
title The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis
title_full The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis
title_fullStr The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis
title_full_unstemmed The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis
title_short The role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis: a systematic review and meta-analysis
title_sort role of estrogen deprivation therapy in premenopausal women with primary unresectable intracardiac leiomyomatosis a systematic review and meta analysis
topic Intracardiac leiomyomatosis
Estrogen deprivation therapy
Primary treatment
Bilateral salpingo-oophorectomy
Gonadotrophin releasing hormone agonists
url https://doi.org/10.1186/s13023-021-02087-7
work_keys_str_mv AT jinxiaoliang theroleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT ruilinlei theroleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT mingweixie theroleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT shaodanlin theroleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT jingxu theroleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT xiaotingling theroleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT qingshengxie theroleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT jinxiaoliang roleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT ruilinlei roleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT mingweixie roleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT shaodanlin roleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT jingxu roleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT xiaotingling roleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis
AT qingshengxie roleofestrogendeprivationtherapyinpremenopausalwomenwithprimaryunresectableintracardiacleiomyomatosisasystematicreviewandmetaanalysis